Published in:
01-08-2013 | Guideline
Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version
JSN, JRS, and JCS Joint Working Group
Authors:
Iwao Ohno, Hiromitsu Hayashi, Kazutaka Aonuma, Masaru Horio, Naoki Kashihara, Hirokazu Okada, Yasuhiro Komatsu, Shozo Tamura, Kazuo Awai, Yasuyuki Yamashita, Ryohei Kuwatsuru, Atsushi Hirayama, Yoshihiko Saito, Toyoaki Murohara, Nagara Tamaki, Akira Sato, Tadateru Takayama, Enyu Imai, Yoshinari Yasuda, Daisuke Koya, Yoshiharu Tsubakihara, Shigeo Horie, Yukunori Korogi, Yoshifumi Narumi, Katsumi Hayakawa, Hiroyuki Daida, Koichi Node, Isao Kubota
Published in:
Clinical and Experimental Nephrology
|
Issue 4/2013
Login to get access
Excerpt
Diagnostic imaging using iodinated contrast media is an essential procedure in the clinical setting, and provides a large amount of beneficial information. However, the use of iodinated contrast media may cause contrast-induced nephropathy (CIN) in patients with chronic kidney disease (CKD), and guidelines on the use of contrast media in this patient population have long been awaited. Although international societies such as the European Society of Urogenital Radiology (ESUR) and the American College of Radiology (ACR) have published guidelines on this matter, no guidelines have been proposed in Japan. Therefore, the Japan Radiological Society (JRS), the Japanese Circulation Society (JCS), and the Japanese Society of Nephrology (JSN) decided to collaborate to establish guidelines on the use of iodinated contrast media in patients with kidney disease. …